Non ST Segment Elevation Acute Coronary Syndrome Clinical Trial
Official title:
Approaches to Differential Diagnosis and Risk Stratification in Patients Hospitalized With Suspected Acute Coronary Syndrome Without Persistent ST-segment Elevation
NCT number | NCT04400500 |
Other study ID # | 01-02/20 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | March 1, 2020 |
Est. completion date | November 30, 2023 |
Verified date | December 2023 |
Source | National Medical Research Center for Therapy and Preventive Medicine |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
To evaluate possibilities of rapid differential diagnosis and risk stratification in patients urgently admitted to the CCU with a suspected acute coronary syndrome without persistent ST-segment elevation (NSTEACS).
Status | Completed |
Enrollment | 140 |
Est. completion date | November 30, 2023 |
Est. primary completion date | November 30, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: 1. Delivered by ambulance to the CCU with suspected diagnosis "acute coronary syndrome (ACS)". 2. Signed informed consent. Exclusion Criteria: 1. ACS with persistent ST-segment elevation. 2. Moribund; extremely severe condition on admission with a potentially unfavourable prognosis (cardiogenic shock, coma, cardiac arrest, an urgent need for mechanical ventilation). 3. Overt non-cardiac cause of clinical manifestations at the time of admission (bleeding, pulmonary embolism, aortic dissection, stroke). |
Country | Name | City | State |
---|---|---|---|
Russian Federation | Eramishantsev Hospital | Moscow |
Lead Sponsor | Collaborator |
---|---|
National Research Center for Preventive Medicine |
Russian Federation,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Urgent revascularisation | Revascularisation performed due to sudden clinical deterioration | Up to 1 monts | |
Other | Other adverse events | All adverse events/complications not included in clinical outcomes end points. | 6 months. | |
Primary | Clinical outcomes | Composite of death, (re) infarction, stroke or re-hospitalization | 6 monts | |
Primary | Final diagnosis | Final diagnosis - the main reason for urgent hospitalization - according to hospital case history | Up to 1 monts | |
Secondary | Death | Death upon discharge and up to 6 months | 6 months. | |
Secondary | (re) infarction | (re) infarction upon discharge and up to 6 months | Up to 1 monts | |
Secondary | Stroke | Stroke upon discharge and up to 6 months | 6 months. | |
Secondary | Re-hospitalization | Recurrent hospital admissions after discharge form the index hospitalization | 6 months. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02892903 -
In the Management of Coronary Artery Disease, Does Routine Pressure Wire Assessment at the Time of Coronary Angiography Affect Management Strategy, Hospital Costs and Outcomes?
|
N/A | |
Recruiting |
NCT05117866 -
Acetyl Salicylic Elimination Trial JAPAN: The ASET JAPAN Pilot Study
|
N/A | |
Recruiting |
NCT02578537 -
COmparison of the Pharmacodynamics and Pharmacokinetics Ticagrelor Versus Clopidogrel in Patients With CKD and NSTE-ACS
|
Phase 4 | |
Recruiting |
NCT06051110 -
Individual Patient Data Meta-analysis on Prehospital Risk Assessment in Patients Suspected of Non-ST-segment Elevation Acute Coronary Syndrome
|
N/A | |
Withdrawn |
NCT03300167 -
Study of the Vascular Response to Percutaneous Coronary Intervention in Patients With Non-ST-elevation Acute Coronary Syndromes Using Intravascular Blood Sampling
|
N/A | |
Terminated |
NCT02071966 -
Study of Effects of Ticagrelor on Microparticles and Micro-RNA in NSTE-ACS
|
Phase 4 | |
Not yet recruiting |
NCT06096909 -
Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population
|
N/A | |
Recruiting |
NCT05125276 -
Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome Patients
|
Phase 4 | |
Recruiting |
NCT03863327 -
EKG Criteria and Identification of Acute Coronary Occlusion
|
||
Completed |
NCT01962428 -
Different LD of Ticagrelor for Antiplatelet Effect in Patients With Non-ST-segment Elevation ACS Undergoing PCI
|
Phase 4 | |
Recruiting |
NCT04476173 -
ANalgesic Efficacy and Safety of MOrphiNe Versus Methoxyflurane in Patients With Acute Myocardial Infarction
|
Phase 3 | |
Recruiting |
NCT06255678 -
Angio-based Final Functional Effect of PCI
|
||
Not yet recruiting |
NCT06197724 -
MCG for Identification of Myocardial Ischemia in Suspected NSTE-ACS Patients
|
||
Recruiting |
NCT05250596 -
COLchicine On-admission to Reduce Inflammation in Acute Coronary Syndrome (COLOR-ACS)
|
Phase 2 | |
Completed |
NCT02073565 -
HARMONEE - Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt
|
N/A | |
Completed |
NCT04766437 -
Optical Coherence Tomography-Guided PCI With Single-Antiplatelet Therapy
|
Phase 2 | |
Not yet recruiting |
NCT05202041 -
Non-IRA Functional Evaluation With AccuFFRangio in NSTE-ACS
|
N/A | |
Recruiting |
NCT02415803 -
Safety and Efficacy of Low-Dose Ticagrelor in Chinese Patients With NSTE-ACS
|
Phase 3 | |
Not yet recruiting |
NCT05779059 -
Prasugrel Or Ticagrelor De-escalation in NSTE-ACS
|
Phase 3 |